CEO at GN Hearing: Properly regulated OTC sales channel could make a difference

Upcoming regulations for the over-the-counter hearing aid market in the US could prove a positive change, as they open up for the treatment of first-time users with mild hearing loss with far better products, CEO at GN Hearing Gitte Aabo assesses.

Photo: GN Store Nord / PR

The opinion on an over-the-counter sales channel for hearings aids in the US hasn't changed at the Danish company GN Hearing. Even now, when the reality of the potential market nears.

Sales of hearing aids without prescriptions was once again a theme of this year's EUHA congress, the annual conference of the European industry association for audiologists, which was held in Hanover, Germany, last week.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs